Company Quick10K Filing
Universal Biosensors
10-Q 2020-06-30 Filed 2020-07-24
10-Q 2020-03-31 Filed 2020-04-24
10-K 2019-12-31 Filed 2020-02-26
10-Q 2019-09-30 Filed 2019-11-04
10-Q 2019-06-30 Filed 2019-07-25
10-Q 2019-03-31 Filed 2019-04-30
10-K 2018-12-31 Filed 2019-02-22
10-Q 2018-09-30 Filed 2018-10-30
10-Q 2018-06-30 Filed 2018-08-13
10-Q 2018-03-31 Filed 2018-04-27
10-K 2017-12-31 Filed 2018-02-23
10-Q 2017-09-30 Filed 2017-10-24
10-Q 2017-06-30 Filed 2017-08-07
10-Q 2017-03-31 Filed 2017-04-27
10-K 2016-12-31 Filed 2017-03-21
10-Q 2016-09-30 Filed 2016-10-20
10-Q 2016-06-30 Filed 2016-07-21
10-Q 2016-03-31 Filed 2016-04-21
10-K 2015-12-31 Filed 2016-03-15
10-Q 2015-09-30 Filed 2015-10-29
10-Q 2015-06-30 Filed 2015-07-23
10-Q 2015-03-31 Filed 2015-04-27
10-K 2014-12-31 Filed 2015-03-12
10-Q 2014-09-30 Filed 2014-10-29
10-Q 2014-06-30 Filed 2014-07-24
10-Q 2014-03-31 Filed 2014-04-25
10-K 2013-12-31 Filed 2014-03-13
10-Q 2013-09-30 Filed 2013-10-30
10-Q 2013-06-30 Filed 2013-08-01
10-Q 2013-03-31 Filed 2013-05-01
10-K 2012-12-31 Filed 2013-03-12
10-Q 2012-09-30 Filed 2012-10-29
10-Q 2012-06-30 Filed 2012-08-06
10-Q 2012-03-31 Filed 2012-05-02
10-K 2011-12-31 Filed 2012-03-13
10-Q 2011-09-30 Filed 2011-11-03
10-Q 2011-06-30 Filed 2011-08-08
10-Q 2011-03-31 Filed 2011-05-05
10-K 2010-12-31 Filed 2011-03-10
10-Q 2010-09-30 Filed 2010-10-26
10-Q 2010-06-30 Filed 2010-08-06
10-Q 2010-03-31 Filed 2010-05-13
10-K 2009-12-31 Filed 2010-03-16
8-K 2020-07-24 Shareholder Vote, Regulation FD, Exhibits
8-K 2020-05-25
8-K 2019-09-18
8-K 2019-09-09
8-K 2019-08-21
8-K 2019-06-27
8-K 2019-06-25
8-K 2019-05-29
8-K 2019-03-08
8-K 2019-02-08
8-K 2018-12-14
8-K 2018-11-20
8-K 2018-09-26
8-K 2018-06-25
8-K 2018-04-23
8-K 2018-04-12
8-K 2017-12-29

Universal Biosensors Financials

UBI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Yummies (YUMM) -1.8 54% 31 10 0 0 17 17 -31
Alliancebernstein (ABLP) 0% -0.9 8% 8,555,271 4,398,256 2,577,571 0 713,248 789,650 -722,030
Liberty Expedia (LEXE) 0% 0.0 -0% 34,646,000 17,341,000 11,536,000 0 -148,000 994,000 8,000
Real Estate Associates IV (REAL4) -0.0 -32% 188 26 0 0 -61 24 -0
Apawthecary Pets (APAW) 0.8 -97% 33 83 0 0 -32 -32 -26
SKY Resort (SKYL) 0.0 -5,741% 2 277 0 0 -126 -126 -0
AEI Income & Growth Fund XXI (AEI21) -1.4 2% 11,113 352 0 0 234 587 -830
Fraud Protection Network (FPNI) 0% -1.4 -208% 731 2,469 1,294 0 -1,518 -1,260 1,774
iShares Gold Trust (IAU) -0.0 -185,563,862,900% 0 0 1,855,639 1,855,639 -0
Federal Home Loan Bank of Dallas (FHLBD) -0.1 0% 73,780,868 70,070,620 0 0 165,578 1,356,628 -153,232
Galenfeha (GLFH) -0% 0 0 0 0 1,638
Rasna Therapeutics (RASP) 0.0 -26% 4,994 2,466 0 0 -1,282 -1,279 -58
Osprey Technology (SFTW) 33.4 -0% 471 451 0 0 -1 -1 -35
CLIC Technology (CLIC) -2.2 -121% 420 1,822 0 0 -508 -502 1,095
Campbell Strategic Allocation Fund (CSAF) -1.3 14% 192,638 4,505 0 0 26,534 26,534 -34,657
Golden Star Resource (GLNS) 0.0 -718% 6 613 0 0 -41 -41 -0
Richmond Mutual Bancorporation (RMBI) -5.9 -0% 956,220 755,866 0 0 -1,543 6,972 -41,377
Toyota Motor Credit (TMCC) -0.8 1% 119,938,000 105,527,000 0 552,000 1,327,000 4,343,000 -3,605,000
DJO Finance (DJO) 0% 12.6 0% 2,012,255 2,866,071 1,203,712 0 1,246 189,365 2,393,844
Stoke Therapeutics (STOK) 14.2 -7% 238,827 5,144 0 0 -16,423 -16,423 -233,254

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash17,48818,81615,08915,69114,71013,93523,64920,22918,09514,67123,74219,46515,87019,83016,33014,81010,72017,35314,35011,33213,21821,64020,40217,78019,95819,83226,26028,51331,13831,76712,13352,23550,89034,823
Accounts Receivable1,2051,2844,8903,4993,2172,3362,2833,1102,4901,9172,1682,0531,8092,0133,8002,9883,9714,2473,1548,2625,4183,4164,8487,8756,1275,7974,3977,5495,4834,90250,2101,0131,203965
Inventory3,2373,0753,6192,4072,4063,0373,6023,5292,2532,384402623943975996575393552922645628399391,1916426628826394817449099641,258
PP&E32,92732,92933,15133,16933,54533,64133,69333,74533,73733,80533,81734,09334,33134,47134,30434,63335,04335,42035,56335,58835,85336,09036,80937,34337,34737,60337,22437,50337,49237,35929,10229,12629,00828,955
Assets45,02245,36045,21643,49342,01041,25249,06746,21442,15741,10354,62050,74747,75446,64747,53347,35845,59646,48844,95245,98044,56241,51249,98950,38750,69149,21446,26248,33248,29589,71769,97862,15561,11660,823
Accounts Payable2866286211,7672,0003,2482,5162,5391,4181,6749759911,6769574817651,3205748951,2881,1458865476058931,0733301,218856473695818754303
Long-Term Debt15,85815,43215,14916,35317,49918,85418,79420,64919,86919,01119,65719,18520,28719,25719,18918,88219,02919,39820,15320,6610
Liabilities4,6637,66210,19410,7959,99310,3049,69511,3069,9989,43224,93624,86025,30326,02727,79230,47230,00631,08131,69634,37234,19933,08036,73534,69234,73834,29133,49335,37735,82735,36419,30414,45214,39514,897
Stockholders' Equity40,35937,69835,02332,69832,01730,94939,37234,90832,15931,67029,68425,88722,45220,61919,74116,88615,58915,40713,25611,60910,3638,43213,25415,69515,95314,92212,76912,95512,46754,35350,67447,70346,72145,927
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue2,7442,4724,3236,4028,3188,6594,7534,8094,7702,5142,9971,3521,5142,0874,5773,1104,3515,9983,3165,0975,4023,2874017,9336,3946,34647,6845,80647,2351,8672,1101,413
Cost of Revenue1416144222636922415785542363191673451887845350734218753328791,1661,2321,2533007125844047171,003823
Gross Profit2,6032,4113,8816,1767,9498,4354,7384,7314,2162,2772,6781,3361,5071,7414,3903,0323,8985,4902,9754,9105,3483,2554,1656,7685,1625,0934,2186,9727,10146,8311,1511,107590
R&D2,9702,3182,7772,2653,1193,7714,3284,4583,4483,9023,6764,9155,2844,7153,2354,9424,9534,9874,8825,0002,8783,9473,1622,0592,3703,1973,2033,8663,4962,7602,1499881,175
SG&A1,8012,0292,0361,4851,5841,6062,1161,3081,4881,6851,7211,3831,6831,5221,0351,6241,5021,5301,3721,4941,0381,4082,4741,6871,8221,6251,8341,7901,9601,3602,0002,2101,600
Tax000000000000000000000000000000000
Net Income-4,910-3,355-3,380-2,402-56-1,326-4,394-4,643-3,041-683-3,267-3,598-3,355-1,894-469-2,868-1,260-163-2,286-1,655462-2,1624,6062,365135-1,181-2,0838470741,866-2,541-959-807
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating1,394-3,49972-429-421-2,522-3,946-2,735-3,499-6,449-3,365-2,2624,075-3,861-465-2,8427,180-4,401-2,3321,8318,960-1,411-1,1452,7365806,519-9595439,745-1,860-7,765
Cash Investing-70-230-87-334-123-144-51-24-60-24-141-260-291-256-277-472-332-190-21-227-63-961-529-196-272-24-234-26-64-5-10,179
Cash Financing43616-218-23012,381576-15-23816,017-218-694-727-154-1,476-818-1,1822,097-108-108-108370-148-117-70-35-2560030